|Publication number||USD600353 S1|
|Application number||US 29/269,724|
|Publication date||Sep 15, 2009|
|Filing date||Dec 6, 2006|
|Priority date||Jun 6, 2006|
|Also published as||CA118561S, CA125206S, CA125207S|
|Publication number||269724, 29269724, US D600353 S1, US D600353S1, US-S1-D600353, USD600353 S1, USD600353S1|
|Inventors||Ralf Kibele, Karin Klokkers, Hans-Jürgen Schlüter|
|Original Assignee||Hexal Ag|
|Export Citation||BiBTeX, EndNote, RefMan|
|Referenced by (1), Classifications (1)|
|External Links: USPTO, USPTO Assignment, Espacenet|
The covering material can in particular embodiments be a transdermal therapeutic system (including comprising a therapeutic agent such as fentanyl) and comprising a face (e.g. face sheet or top layer) with imprint including a line, which can be continuous or dashed, which imprint can be suitably provided e.g. by a removable film.
The broken lines shown in the internal portion of the covering material represent a continuous or dashed line which is ornamental and is included as part of the claimed design.
|Citing Patent||Filing date||Publication date||Applicant||Title|
|USD757280 *||Jul 22, 2014||May 24, 2016||Lotte Co., Ltd.||Heat pad|